Monthly Archives

September 2025

Secukinumab Therapeutic Cheat Sheet

By Medical Dermatology

secukinumab

ODAC shares practical, clinically relevant updates in medical dermatology. Our partner Next Steps in Derm shares this new cheat sheet for prescribing and managing patients on secukinumab.

Learn secukinumab’s mechanism of action and dermatologic uses. Know side effects, and warnings and precautions. Plus find out what baseline lab monitoring you should order.

The Secukinumab Therapeutic Cheat Sheet is available online and in a downloadable and printable PDF.

Register for ODAC and learn the latest in treating psoriasis, psoriatic arthritis, hidradenitis suppurativa, and other dermatologic conditions where secukinumab is a treatment option.

Surgical Reconstruction Pearls

By ODAC Sessions

surgical reconstruction pearls

Think outside the box. That’s the direction of dermatologic surgeon Timothy C. Flynn, MD, FAAD, to dermatologists conducting surgical reconstruction.

Watch this Next Steps in Derm video interview with Dr. Flynn from ODAC 2025 where he shares questions dermatologists should ask when addressing a wound. Find out why considering shadows and highlights is important for positive outcomes and which aspects of beauty to consider when conducting surgical reconstruction.

Register for ODAC 2026 for more surgical dermatology pearls.

Neuromodulator Complications: ODAC Pearls with Dr. Watchmaker

By ODAC Sessions, Uncategorized

neuromodulator complications

At the 2025 ODAC Dermatology Conference, Jacqueline Watchmaker, MD, shared how to assess and manage neuromodulator complications. Here are some highlights from her session:

  • With heavy eyelids, Dr. Watchmaker says it’s crucial to determine whether the issue lies with the brow or the eyelid itself.
  • Brow ptosis is caused by too many units overall in the frontalis, too many units too low or lateral in the frontalis, or diffusion of neuromodulator from the glabellar complex to the lower frontalis.
  • Watchmaker suggests adding units to the depressor muscles (procerus/corrugators/orbicularis oculi) to help lift the brow. Also, with time, she says the neurotoxin’s effects will naturally fade, resolving the brow ptosis without intervention.
  • A “crooked smile” effect can happen when inadvertently injecting the depressor labii inferioris (DLI) muscle. Injecting one unit of the neuromodulator into the contralateral DLI muscle will lessen the effect naturally in a few weeks.
  • A “shelf” appearance under the eye occurs when too much neuromodulator is injected into the orbicularis oculi muscle. This may be prevented by using only 1-2 units for the most inferior injection.
  • Patients also may notice more prominent “sleep lines” post-injection. She recommends patients wear hydrocolloid bandages at night if the lines are bothersome.
  • Watchmaker also debunks several myths that are often shared with patients after neuromodulator injections, including not bending down or lying down for four hours post-injection, or not working out for 24 hours.
  • Watchmaker says there is limited data regarding whether exercising facial muscles or taking oral zinc help prolong a neuromodulator’s duration.

This session summary was written by Vixey Silva, DO, and published on Next Steps in Derm.

Register for ODAC 2026 for more pearls on preventing and managing complications.

 

Acne 2025 Update: ODAC Highlights

By ODAC Sessions

acne treatment

What’s in vogue in the treatment of acne in 2025? Isotretinoin! A resurgence in the use of isotretinoin is one of the latest developments in the treatment of acne, according to dermatologist and researcher Neal Bhatia, MD, FAAD.

Dr. Bhatia spoke with Next Steps in Derm about his ODAC 2025 session on acne. Watch as he shares new therapeutic developments as well as key points in acne patient education.

Register for ODAC 2026 and attend Dr. Bhatia’s sessions on treating actinic keratosis and optimizing photodynamic therapy outcomes.